{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:26:59Z","timestamp":1761744419828},"reference-count":14,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.transproceed.2016.03.028","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T04:30:42Z","timestamp":1480998642000},"page":"3099-3105","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report"],"prefix":"10.1016","volume":"48","author":[{"given":"B.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mompoint-Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.D.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Stegner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Locke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2016.03.028_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5500\/wjt.v4.i1.18","article-title":"ABO incompatible renal transplants: good or bad?","volume":"4","author":"Muramatsu","year":"2014","journal-title":"World J Transplant"},{"key":"10.1016\/j.transproceed.2016.03.028_bib2","unstructured":"MacLennan PA, Kumar V, Reed RD, Mompoint-Williams D, Stegner K, Locke JE. Risk of acute rejection among ABO incompatible living donor kidney recipients. Abstract accepted for presentation at the 2016 American Transplant Congress\u00a02016."},{"key":"10.1016\/j.transproceed.2016.03.028_bib3","first-page":"338","article-title":"Nephrology self-assessment program","volume":"12","author":"Cohen","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2016.03.028_bib4","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.transproceed.2012.03.053","article-title":"Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant","volume":"44","author":"Stewart","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.03.028_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","article-title":"The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.03.028_bib6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1600-6143.2006.01709.x","article-title":"The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection","volume":"7","author":"Locke","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.03.028_bib7","unstructured":"Alexion. European commission grants orphan drug designation to soliris (eculizumab) for the prevention of graft rejection following solid organ transplantation. Web: Alexion Pharmaceuticals;\u00a02014. Available from http:\/\/news.alexionpharma.com\/press-release\/product-news\/fda-grants-orphan-drug-designation-soliris-eculizumab-prevention-delayed. Last accessed July 21, 2015."},{"key":"10.1016\/j.transproceed.2016.03.028_bib8","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1111\/j.1600-6143.2010.03191.x","article-title":"Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access","volume":"10","author":"Lonze","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.03.028_bib9","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/j.1432-2277.2011.01290.x","article-title":"Prompt reversal of\u00a0a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation","volume":"24","author":"Biglarnia","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2016.03.028_bib10","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.03.028_bib11","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1111\/j.1600-6143.2012.04124.x","article-title":"Antibody mediated rejection associated with complement factor h-related protein 3\/1 deficiency successfully treated with eculizumab","volume":"12","author":"Noone","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.03.028_bib12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.transproceed.2013.02.062","article-title":"Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: case reports","volume":"45","author":"Kocak","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.03.028_bib13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/tri.12396","article-title":"Antibody-mediated rejection despite inhibition of terminal complement","volume":"27","author":"Bentall","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2016.03.028_bib14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/TP.0000000000000298","article-title":"Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation","volume":"98","author":"Orandi","year":"2014","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516301336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516301336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T05:51:11Z","timestamp":1536213071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134516301336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0041134516301336"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.03.028","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}